By Sean Moloughney, Editor09.09.19
With 30% of the U.S. population classified as obese, related issues like diabetes and cardiovascular disease are significant health concerns contributing to a sizable public health crisis.
Sales of weight loss supplements, including meal replacements, are expected to near $7 billion by 2022, according to estimates from Nutrition Business Journal (NBJ). With 157 million (69%) U.S. adults overweight or obese, not surprisingly, weight control tops the list of health benefits consumers would most like to get from foods/beverages.
Overall, the market for functional nutrition products continues to evolve, especially as research unravels the role the gut microbiome plays in health and weight, said Juliana Erickson, senior marketing manager, Lonza Consumer Health & Nutrition. “Keto and paleo diets, as well as vegan and vegetarian lifestyles, are also becoming increasingly popular with health-conscious consumers due to their perceived health benefits.”
The challenge with exclusion diets, however, is that individuals may miss out on beneficial nutr
Sales of weight loss supplements, including meal replacements, are expected to near $7 billion by 2022, according to estimates from Nutrition Business Journal (NBJ). With 157 million (69%) U.S. adults overweight or obese, not surprisingly, weight control tops the list of health benefits consumers would most like to get from foods/beverages.
Overall, the market for functional nutrition products continues to evolve, especially as research unravels the role the gut microbiome plays in health and weight, said Juliana Erickson, senior marketing manager, Lonza Consumer Health & Nutrition. “Keto and paleo diets, as well as vegan and vegetarian lifestyles, are also becoming increasingly popular with health-conscious consumers due to their perceived health benefits.”
The challenge with exclusion diets, however, is that individuals may miss out on beneficial nutr
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
